Brain tumor radiation gets a smart upgrade: MR-Linac trial aims to boost power, cut harm
NCT ID NCT07457307
First seen Mar 20, 2026 · Last updated May 01, 2026 · Updated 8 times
Summary
This early-stage trial tests whether a new radiation technique using an MRI-guided machine (MR-Linac) can safely deliver higher doses to aggressive brain tumors (grade 3 or 4 gliomas). Twenty adults who have recently had surgery will receive radiation doses tailored to how much tumor remains, based on a special surgical assessment. The main goal is to check for severe side effects, while also tracking how long patients live without the cancer growing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Langone Health
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.